Clinical Trial Update: Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares rectus femoris tenotomy to botulinum toxin A for improving stiff knee gait after stroke; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Stroke

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: University Hospital of Mont-Godinne | Conditions: Stroke, Spasticity | Phase 4 | Status: UNKNOWN